Cormorant Asset Management, 10% Owner: Bright Minds Biosciences DRUG Buy · Filed 24/10/17

Trade details

Type: Insider buy
Amount: $214,062.06
Shares · price: 33,343 sh · $6.42 a share
Held after: 787,022 sh
Stock: Bright Minds Biosciences DRUG
Person: Cormorant Asset Management10% Owner
Trade date: 24/10/15
Filed: 24/10/17
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +4.4%

Bright Minds Biosciences trades, last 26 weeks

What else happened in Bright Minds Biosciences around then

Filed or reported within 30 days of the trade day · 24/09/15~24/11/14

Cormorant Asset Management's recent trades

Cormorant Asset ManagementOther
SellBright Minds Biosciences
Sell
Bright Minds Biosciences
DRUG
$9.8M
109,331 sh
$9.8M
Filed 04/30
Traded 04/28
Cormorant Asset Management10% Owner
SellCorbus Pharmaceuticals Holdings
Sell
Corbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
Cormorant Asset ManagementOther
SellEyePoint
Sell
EyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29

Cormorant Asset Management, 10% Owner — bought $214.1K of Bright Minds Biosciences DRUG · 33,343 sh @ $6.42 | Whalegun